Sigma-Aldrich Production
Switzerland Updated 9 July 2026
Sigma-Aldrich Production is an API manufacturer based in Switzerland. It holds one active US drug master file across a filed portfolio of 2 molecules. Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 22 September 2023 as NAI.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 22 September 2023 NAI US FDA
- 2 September 2016 NAI US FDA
- 26 July 2012 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Switzerland, Switzerland | 3005258198 |
| Buchs Sg, Switzerland | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Dimethyl | SFDA (Saudi Arabia) | 1 |
| Mebrofenin | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| EMA | None | 1 |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Sigma-Aldrich Production comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 22 September 2023.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates